“I am a firm believer that this is India’s decade and that we are going to see something similar to what we saw during 2003-2008.”

“There are many opportunities in the chemicals and pharma spaces where over the next five-10 years, significant value will get created.”

“It is better to seek opportunities in pockets where valuations are still reasonable and where you have not seen an out-of-turn or a signif...

Earnings trajectory for IT companies is going to continue upwards over the next two to three years and definitely for the next two to four ...

Cement will be a beneficiary of infrastructure and real estate picking up, says Anshul Saigal.

With a 3.62% return, ICICI Prudential Largecap Portfolio emerged as the top gainer in May.

BSE benchmark Sensex is down 17 per cent for last three months.

In 2003-5, during second Iraq war, markets went up meaningfully for both largecaps and mid and smallcaps.

Looking at results on a quarterly basis and in absolute terms not the right way to assess opportunities.

Quality names in auto, FMCG and consumer staple space have corrected 30-70%.

Go for quality businesses trading at reasonable valuations, with potential for growth, says Saigal.

If you get perturbed by volatility, you will miss out on opportunities, says Saigal.

Going forward, fundamentals or earnings growth will have to justify valuations, says Saigal.

One has to be very picky and choosy in terms of valuation, says CIO of Kotak PMS

This comes following a net inflow of Rs 1.4 lakh crore in last eight months.

The pharma fund category lost 5%, while the technology segment is down 3% in the past year, according to Morningstar. During the same perio...

Pharma funds have lost 5 per cent, while the IT segment is down 3% in the past year.